Health Economics

This recently launched service is provided primarily for Australian requirements. Leveraging Novotech’s existing infrastructure in drug development services, in conjunction with our late phase services our Health Economics offering caters to the following needs:

• Preparation of reimbursement strategies and applications
• Systematic reviews and meta-analysis
• Economic modelling
• Health outcomes research and disease management strategies
• Pharmacoepidemiology studies